Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Buy
15,717
+528
+3% +$32.3K ﹤0.01% 1435
2026
Q1
$1.05M Buy
15,189
+1,956
+15% +$151K 0.01% 1269
2025
Q4
$1.01M Buy
13,233
+1,075
+9% +$86.3K 0.01% 1216
2025
Q3
$1.05M Sell
12,158
-987
-8% -$74.5K 0.01% 1068
2025
Q2
$897K Buy
13,145
+65
+0.5% +$4.03K 0.01% 1035
2025
Q1
$793K Sell
13,080
-238
-2% -$15.1K 0.01% 914
2024
Q4
$806K Sell
13,318
-5,193
-28% -$318K 0.01% 863
2024
Q3
$1.33M Buy
18,511
+3,992
+27% +$279K 0.03% 459
2024
Q2
$1.01M Buy
14,519
+5,643
+64% +$434K 0.04% 351
2024
Q1
$707K Buy
+8,876
New +$716K 0.1% 209

Other funds holding APTV

&Partners's APTV Position: Q2 2026 in Review

&Partners increased its Aptiv (APTV) stake by 3.5% in Q2 2026, buying an estimated $32.3K and bringing the position to 15,717 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

&Partners first reported a position in APTV in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.33M in Q3 2024. 661 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • &Partners held 15,717 shares of Aptiv worth $965K as of Q2 2026.
  • &Partners bought 528 Aptiv shares in Q2 2026, an estimated $32.3K.
  • Aptiv made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1435 holding.
  • &Partners first reported a position in Aptiv in Q1 2024 and has held it in 10 quarters since.
  • &Partners's Aptiv position peaked at $1.33M in Q3 2024.
  • 661 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.